Abstract of Lactate Dehydrogenase (LDH)
Lactate Dehydrogenase (LDH), is a tetrameric
enzyme composed of two subunits LDHA and LDHB. LDH primarily functions to
convert pyruvate into lactate and nicotinamide adenine dinucleotide (NADH) to
NAD+. LDHA is of interest as cancer cells metabolism utilizes LDHA
to elevate rate of anaerobic glycolysis even in the presence of oxygen. Thus,
LDHA is an attractive enzyme for studies to develop novel cancer specific
therapies. In our experiment, it was essential to determine if cloned rLDHA
from previous experiment was able to be expressed successfully while retaining
its biological function of converting lactate to pyruvate. This was achieved by
IPTG induction, enzyme assay, SDS-PAGE and western blotting. Through IPGT
induction, it allowed T7 RNA polymerase to be expressed leading to rLDHA
overexpression. Presence of rLDH was determined by enzyme assay through its
catalytic activity of lactate to pyruvate. Result obtained was positive. To
further characterized rLDH, SDS-PAGE was used and result showed a 36 kDa band
which was approximately similar to known LDHA molecular weight of 35 kDa.
Western blotting further confirmed SDS-PAGE result with signal amplification at
36 kDa band. Overall, expression and functionality of cloned rLDHA was checked
for and with high confidence able to undergo downstream experiments, studying
of protein structure and development of novel therapeutic agents.
1.0 Introduction of Lactate Dehydrogenase (LDH)
Lactate Dehydrogenase (LDH) is a tetrameric
enzyme which converts Pyruvate to Lactate by reducing nicotinamide adenine
dinucleotide (NADH) to NAD +. LDHA is generally
in the form of tetramer. It consists of almost 332 amino acids, which help it
in formation of biolab structure. As the main function of LDHA is the
conversion of pyruvate to lactate and to transfer NADH to NAD+. LDHA
activate when substrate and cofactor attach. The activated site is present at
the groove in between two domains will get close. Eventually, Arg 105 will grip
pyruvate strongly in activated circles. On the other hand, hydrogen anion will
get transfer from NADH ring to oxygen atom. LDHA is located in cytoplasm of the
cell but sometimes it also been found in nucleus or mitochondria. In cytoplasm
it plays its role in glycolysis but it works as DNA binding protein inside the
nucleus where it also takes part in DNA duplication and transcription. (1) maintain glycolysis, (2) generate
sufficient Adenosine Triphosphate (ATP) for energy when oxidative
phosphorylation route is affected. LDH has 5 isoforms composed of LDHA (M
subunit) and LDHB (H subunit). Distribution areas include: LDH-1(4H) in red
blood cells and muscle, LDH-2 (3H,1M) in white blood cells, LDH-3 (2H,2M) in
lungs, LDH-4 (1H,3M) in kidney, pancreas and placenta and LDH-5 (4M) in
skeletal muscle and liver. Cancer cells metabolism utilizes LDHA to enhance
aerobic glycolysis even in presence of oxygen for rapid cell proliferation
(Kim, 2006). The metabolism process in cancer cells is
quite different from the non-transformed cells. This help them to get excess of
biomaterials and energy for much proliferation. Reprogrammed metabolism helps
in resisted cell death and some more malignant characters. If the glycolysis is
accelerated it will help in some important aspects of cancer metabolism.
Accelerated level of glycolysis can help biomolecules present in cell by
supplying them with precursors. Glycolysis involve the production of lactate
which contribute on larger scale in the process of malignant progression such
as replenishing NAD+ the purpose of glycolysis, enhancing immune escape or
decrease in pH for invasion. Lactate dehydrogenase A work in converting
pyruvate to lactate and vice versa. So, the LDHA activation has a relation with
diverse cancer. In this way we can say that LDHA can act as a target for
prevention and treatment of cancer. Thus,
LDHA is of interest in cancer research to develop cancer therapeutic agents.
For example, LDHA can be degraded by acetylation of at Lysine-5 through
hypothesized chaperone-mediated autophagy (Zhao, 2013). Previous molecular
cloning experiment confirmed rLDHA gene had a silent mutation hence, not
impeding protein expression. As eukaryotic rLDHA was expressed in bacteria
host, complications may arise, e.g. misfolding. Using the same pET11-H6α vector, the following interest was to express functional rLDHA, required for
downstream experiments (e.g. studying of LDH structure to develop novel cancer
therapeutic agents). To conclude with confidence that cloned rLDHA were
functional, rLDHA overexpression, purification and characterization was done
through: (1) IPGT induction, (2) specific enzyme assay, (3) SDS-PAGE and
western blotting. If functional, LDH enzyme would convert pyruvate to lactate
and vice-versa. rLDHA were first overexpressed to provide ample yield for
subsequent experiments. BL21(DE3) E. coli utilized T7 expression system
to overexpress rLDHA via strong bacteriophage T7 promotor. T7 promoter in pET11-H6α vector, caused BL21(DE3) E. coli cells
to divert its resources to synthesis rLDHA proteins rather than its own
endogenous proteins (control to maximize protein field). Log phase was optimum
to express rLDHA where cells were the fittest, dividing exponentially and
expressed chaperones to remove misfolded proteins (Betts, 2002). Upon IPGT
induction, lac repressor was inactivated, allowing expression of T7 RNA
polymerase facilitated by E. coli polymerase to occur and overwhelming T7
lysozyme inhibition produced by pLysS plasmid. Binding of T7 RNA polymerase to
T7 promotor allowed overexpression of rLDHA (Kang, 2007). OD was measured
before and after IPGT induction to ensure cells were at log phase and no cell
death observed respectively. To obtained purified rLDH, BL21(DE3) E.
coli cells were lysed with repeated cycle of freezing and thawing, disrupting
cell wall through ice crystal formation. Lysis was aided by cytoplasmic T7
lysosome via degradation of cell wall. PMSF and Dnase 1 was added to inhibit
activated protease and digest nucleic acid to removed viscosity respectively.
Cells were centrifuged to pellet proteins to the bottom and cell debris to
supernatant. To isolate purified rLDH, Ni-NTA affinity chromatography was used.
Choice of correct buffer, ionic strength and pH was necessary to keep proteins
soluble, protect integrity and maintained physiological pH for stability. pH
7.4 stock phosphate buffer was chosen to prepare Ni washing, binding and
elution buffer. Ni2+ ions immobilized on nitrilotriacetic acid (NTA)
sepharose resin had high affinity for rLDH due to 6x His-tag allowing rLDH to
bind with higher affinity than non-target proteins via dative bonding of
nitrogen atom in histidine molecules. Low concentration of Imidazole (washing
buffer) was used to removed non-specific proteins followed by high
concentration of imidazole (elution buffer) to elute purified rLDH. To test for
rLDH successful expression, functionality and purity in purified fractin,
protein assay coupled with specific enzyme activity assay were utilized. BSA
protein assay allowed detection of protein presence through dye
colour change from brown to blue. Protein absorbance were measured at 595nm and
BSA protein standard curve was
used to estimate unknown protein sample concentration (mg/ml) required for
calculation of specific enzyme activity and total enzyme activity. Enzyme assay
used NADH product formation as rLDHA identifier as it was distinguishable from
other components of the reaction at 340 nm. Product formation (ΔA/min) was measured via spectrophotometer at 340nm
over 3 minutes using L-lactate and NAD+ as substrate and co-factor
respectively. Enzyme activity was calculated by Beer’s law: A =
εbc. Specific enzyme activity was calculated to determine purity of rLDH after
purification. Purification
factor and percent yield were calculated to determine effectiveness of
purification step and preservation of enzyme activity after purification
respectively. SDS-PAGE was used as a semi-qualitative test to determine
successful rLDH expression and purity through relative molecular mass, band
intensity/thickness and number of bands in purified sample. If purification was
successful, a single band of 35 kDa (known size of LDHA) would be observed.
Successful overexpression was determined by comparing LDH band intensity
between induced and non-induced sample. Proteins molecules were separated via
application of electric field with smaller molecules migrating faster than
larger molecules due to restrain from polyacrylamide gel pores. SDS being an anionic
detergent function to confer negative charge to proteins and denature proteins
to its primary structure. As charge-to-mass ratio are approximately same across
SDS denatured polypeptides, separation of proteins was dependent on relative
molecular mass (ThermoFisherScientific, 2020). Coomassie blue was used to stain
and fixed protein bands. As dye binds stronger to proteins than gel matrix, it
allowed removal of dye from protein free areas conferring blue stained protein
bands for visualization. Western blotting was used to detect presence of rLDHA
using specific antibodies. After SDS-PAGE, protein bands were electro
transferred onto PVDF membrane. Milk proteins were added to prevent
non-specific primary antibody binding to PVDF membrane, reducing signal-to-noise
ratio. Indirect method with secondary antibody conjugated to horseradish
peroxidase was used to detect rLDHA through signal amplification. Horseradish
peroxidase substrate DAB and 4CN were added in conjunction to enhance
visibility of rLDHA band. Overall, enzyme assay, SDS-PAGE and western blotting
was used as triple conformational test to provide evidence for presence of LDH
enzyme.
2.0
Results of Lactate Dehydrogenase (LDH)
2.1 OD
readings of bacteria culture before and after IPTG induction
Table
1: Optical density reading recorded at 600 nm before and after
IPTG inductionTable
1 description: Bacterial culture was allowed to attained OD600
at 0.46 before 1mM IPTG was introduced. From table 1, OD600 of
0.46 suggested that bacteria cells were in early log phase and ready for
induction. Log phase was where cells were most active. From table 1, upon
induction for 3 hr, bacteria culture OD600 reached 1.78. This
suggested that bacteria cells continued to grow and increase in population
reaching mid-stationary phase.
2.2
Normalized average absorbance and protein concentration of fractions
Table
2: Normalized average absorbance of protein samples
measured at 595 nm using plate reader.
|
Average corrected absorbance
|
[Protein] mg/mL
|
|
Neat
|
2X
|
5X
|
10X
|
50X
|
100X
|
Uninduced
|
1.38
|
|
|
0.79
|
0.24
|
0.12
|
18.6
|
Induced
|
0.99
|
|
0.67
|
0.16
|
0.09
|
11.9
|
Flow through
|
0.89
|
|
0.47
|
0.12
|
0.08
|
9.30
|
Purified sample
|
0.37
|
0.21
|
0.08
|
0.04
|
|
|
0.64
|
Table
2 description: Sample fractions absorbance were normalised. 50x
dilution for uninduced, induced and flow through and 2x dilution for purified
fraction were selected to estimation of protein concentration (appendix).
From Table 2, it was observed uninduced fraction had the highest absorbance
followed by induced, flow through and purified sample. This was proportionate to
protein concentration as seen in Table 2. However, induced sample contained
lower protein concentration than uninduced sample as seen in Table 2 (discussed
in…).
2.3
Purification summary table of fractions
Table
3: Purification summary table of fraction samples to estimate
purity and presence of rLDHA.
|
(Protein) mg/ml
|
ΔA/min
|
Enzyme
activity (nM/min)
|
Specific
enzyme activity (μmol/min/mg)
|
Total enzyme activity (μmol/min)
|
Purification
factor
|
Percentage
yield (%)
|
Neat
|
10X
|
50X
|
Uninduced
|
18.6
|
0.03
|
|
0.004
|
0.03
|
|
|
|
Induced
|
11.9
|
|
0.14
|
0.023
|
12.5
|
148.9
|
1
|
1
|
Flow
through
|
9.30
|
0.15
|
|
0.024
|
0.33
|
3.05
|
0.03
|
2.05
|
Purified
sample
|
0.64
|
|
0.07
|
0.012
|
120.3
|
30.9
|
9.63
|
20.8
|
a Total
protein concentration (mg/ml) estimated from BSA standard curve using
equation of straight line y = 0.6505x
b Enzyme
activity (nM/min) calculated using: ΔA per min/6.22 mM-1.cm-1.
c
Specific activity (μmol/min/mg) calculated using:
Enzyme activity/Protein concentration used in 2.6 ml reaction volume.
dPurification
factor is the quotient of rLDHA specific activity after Ni-NTA affinity
chromatography.
e
Percentage yield represents the recovery of each fractions after Ni-NTA affinity
chromatography relative to crude induced sample.
|
Table
3 description: Sample fractions NADH product ΔA/min was measured
(described in methods). Neat uninduced and flowthrough fraction and 50x
dilution induced and purified fraction were chosen for assay. From Table 3, it
was observed significant enzyme activity (nM/min) was present for all fraction
except, uninduced sample. This suggested: (1) uninduced sample contained low levels
of rLDH (2) presence of rLDH, due to NADH product formation observed. To
determine rLDHA purity in fractions, specific enzyme activity (umol/min/mg)
was calculated. From Table 3, it was observed purified fraction had highest
specific activity of 120.3 μmol/min/mg
while uninduced fraction had the lowest specific activity followed by flow
through fraction. Enzyme activity and specific activity from Table 3 suggested:
(1) purified fraction was of highest rLDH purity, with with 9.63 times more
rLDH than induced fraction after Ni-NTA affinity chromatography. (2) Flow
through fraction mostly contained junk proteins due to low specific activity
compared to initial induced and purified fraction thus, column was efficient in
isolating rLDHA to purified fraction. (3) Overexpression was successful
due to huge increased specific activity in induced fraction compared to
uninduced fraction thus, pLysS in BL21(DE3) E. coli bacterial cells was
functioning to inhibit leaky expression of T7 RNA polymerase. Percentage yield
was calculated to determine how well enzyme activity was preserved after Ni-NTA affinity
chromatography. From table 3, it was observed that
purified sample had a yield of 20.8 %. This suggested that there was a
significant loss of rLDH activity. In addition, purification and flow through
fraction did not add up to approximately 100 % yield.
2.3 SDS-PAGE of
fractions for purity and presence of rLDHA
Figure 1 description: In semi-qualitative SDS-PAGE test, purified
fraction was compared against other fractions to determine molecular weight,
abundance and purity of rLDHA. Protein concentration of 4 μg was
standardized among fractions. Results were presented in Fig. (1). It can be
noticed from Fig. (1) lane 7 had a thick protein band of 36 kDa (green arrow)
and reduction of protein bands after purification of initial induced fraction
(lane 5). Removed protein bands can be observed in lane 6. This suggested (1)
36 kDa band was rLDHA due to co-migrating with positive control LDHA, (2)
purified fraction was purer in rLDH after Ni-NTA affinity chromatography from induced fraction, (3) Column had
effective binding due to minimal rLDHA present in flowthrough fraction as dull
36 kDa band (purple arrow) was observed in lane 6. It also can be noticed from
Fig .(1), lane 5 had a brighter 36 kDa band (orange arrow) than lane 4 (blue
arrow). This suggested after IPGT induction 36 kDa band protein molecules were
overexpressed and inhibition by pLysS in BL21(DE3)
E. coli bacterial cells was working. This provided further evidence 36 kDa band was
rLDHA as IPGT induction was used to overexpressed rLDHA Positive control in
lane 8 contained purified LDHA was used to determine if rLDHA had similar
molecular weight. Co-migration of positive control LDHA band to 36 kDa (cyan
arrow) suggested that purified sample 36 kDa band was most likely rLDHA.
However, unknown protein bands (red arrow) were observed in lane 6 and
intensity of lane 4 smearing were not consistent with lane 5 and 6 though,
equal proportions of 4 μg proteins were loaded.
2.4 Relative mobility and estimated molecular
mass of protein bands from SDS-PAGE
Table 4: Estimated molecular mass from protein ladder standard curve (refer to
appendix).
|
Expected
LDHA
|
Uninduced
rLDHA
|
Induced
rLDHA
|
Flowthrough
rLDHA
|
Purified
rLDHA
|
Positive
control
|
Unknown
protein
1
|
Unknown
protein
2
|
Unknown
protein
3
|
Rf
|
|
0.68
|
0.68
|
0.68
|
0.68
|
0.68
|
0.40
|
0.81
|
0.85
|
Protein Size (kDa)
|
35
|
36
|
36
|
36
|
36
|
36
|
79
|
25
|
22
|
Table 4
description: Protein molecular
weight estimated from standard curve of known protein standards using equation
of straight line: y = -1.2449x + 2.4075. Suspected rLDHA molecular mass were
computed based on relative mobility. From table 4, suspected rLDHA molecular
mass was 36 kDa which was a close approximate to expected LDHA of 35 kDa. This
provided further evidence 36 kDa band was highly probable to be of rLDHA.
Unknown protein bands of lane 6 in Fig.1 molecular weight observed in purified
sample were computed. (discussed in).
2.5
Western blotting of fractions for presence of rLDHA
Figure 2 description: In a semi-qualitative western blotting
test, presence of rLDHA was detected using indirect detection method as
described in methods section. Protein concentration of 4 μg was
standardized among fractions. Intensity
of signal amplification was compared between fractions. The results were
presented in Fig. (2). It can be noticed from Fig. (2) only a single 36 - 37
kDa band had signal amplification. This confirmed 36 kDa band observed from
SDS-PAGE was indeed rLDHA as antibody used were specific to rLDHA. It also
indicated primary antibody was specific as no unspecific binding were observed.
It can be noticed from Fig. (2), Lane 7 had high signal amplification, lane 4 had moderate signal amplification while
lane 3 and 5 had low signal amplification. This indicated: (1) Purified
fraction had highest rLDHA concentration as equal proportion of proteins (4 μg) were
loaded, (2) rLDH were successfully overexpressed from uninduced to induced
fraction after IPGT induction, (3) pLysS plamid in BL21(DE3)
E. coli bacterial cells was working, (4) flow through fraction
contained low levels of rLDHA due to majority of rLDHA being bounded to column
(good binding efficiency). In addition, western blotting results indicated
unknown protein bands seen in purified fraction of SDS-PAGE in Fig (1), were
junk proteins due to no observed signal amplification at 22, 25 and 79 kDa. Positive control
in lane 9 contained purified LDHA and its signal amplification validated 36-37
kDa band were rLDHA. However, partial degradation can be observed in lane 4 and
7 (discussed in).
2.4 Relative mobility and estimated molecular
mass of protein bands from SDS-PAGE
Table 5: Estimated molecular mass from protein ladder standard curve (refer to
appendix).
|
Expected
LDHA
|
Uninduced
rLDHA
|
Induced
rLDHA
|
Flowthrough
rLDHA
|
Purified
rLDHA
|
Positive
control
|
Rf
|
|
0.684
|
0.684
|
0.684
|
0.689
|
0.689
|
Protein Size (kDa)
|
35
|
36
|
37
|
37
|
36
|
36
|
Table 5
description: Protein molecular
weight estimated from standard curve of known protein standards using equation
of straight line: y = -1.489x + 2.5959. rLDHA molecular weight were computed
based on relative mobility. From table 5, signal amplified bands had
approximately same molecular mass with expected LDHA of 35 kDa. This indicated
that 36 kDa was rLDHA.
3.0 Discussion of Lactate Dehydrogenase (LDH)
3.1 OD readings of bacteria culture
before and after IPTG induction
OD
readings were monitored prior to IPGT induction to ensure bacteria cells
reached log phase. Readings obtained was 0.46 OD as seen in Table 1, where
bacterial cells were at early log phase and ready for IPTG induction. Log phase
was specifically chosen to induce IPGT as total number of bacteria cells were
increasing exponentially and actively producing proteins for replication.
Induction of IPGT allowed bacteria cells to diverts its energy and resources to
synthesized rLDHA proteins while slowing down bacteria replication (control to
maximise protein field). This is due to IPTG activating T7 RNA polymerase
promotor which was a stronger promoter than host RNA polymerase promotor for
gene expression. Furthermore, T7 RNA polymerase being a highly active enzyme,
enhanced transcriptional activity of rLDHA rates several times higher than
E.coli RNA polymerase and terminated transcription less frequently (Tabor,
2001). Lag phase was not chosen for induction as total number of bacteria cells
were extremely low thus, affecting protein production and yield. Stationary
phase was not chosen for induction as nutrients would have been depleted,
affecting cells ability to express genes though, it contained highest number of
bacteria cells (Zwietering, 1990). OD
reading after IPTG induction was 1.78, indicating late stationary phase.
Increased in bacteria cells over time provided evidence that 1mM IPGT was not
potent enough to kills cells, rLDHA was not toxic and incubation period was not
too long (cells were not at death phase). If rLDHA was toxic or 1nM IPTG was
too strong for bacteria cells, OD value would not increase much, may not change
or decreased from 0.46 OD. If bacteria were in death phase OD reading would
decrease from 0.46 OD.
3.2
rLDHA successful expression and functionality of Lactate
Dehydrogenase (LDH)
IPTG
induction was used to express rLDHA gene located in pET11-H6α
plasmid. IPTG induction mechanism was described in 3.1. To determine if rLDH in
pET11-H6α plasmid silent mutation had no effect (e.g. no truncation) on protein
expression and function, specific enzyme activity was conducted. As LDH is a
protein catalyst, assay was based on its known enzymatic reaction of oxidising
lactate to pyruvate using NAD+ as cofactor. By measuring the
distinguishable absorbance property of reduced NADH at 340 nm, served as rLDH
identifier. Based on results of Table 2, all fractions excluding uninduced
sample had a significant increase in enzyme activity (nM/min). This gave an
insight expressed rLDH was functional due catalytic ability to convert lactate
substrate (provided in reaction) to pyruvate. Low enzyme activity was present
in uninduced fraction due to inhibition of T7 RNA polymerase synthesis by lac
repressor, while leaky expression was inhibited by T7 lysozyme of pLysS plasmid. However, this
was not sufficient to prove rLDHA presence as unknown enzymes produced by host bacterial cells could utilized lactate as substrate. To further
prove enzymatic activity was caused by the effect of rLDH, SDS-PAGE and Western
blotting results were investigated. Since SDS-PAGE denatured rLDH to its
primary structure, characterization was determined by its subunit LDHA known
molecular weight of 35 kDa. Equal proportions of 4 μg of protein was loaded and difference
in thickness/brightness of similar band will indicate higher concentration.
Firstly, to characterize rLDH, purified fraction was look into. If purification
was successful, a single band would be observed. Though, 4 bands were observed,
36 kDa band was of interest due to: (1) being approximately similar to
expected LDHA band of 35 kda, (2) positive control containing pure LDHA
co-migrated to 36 kDa. Western blotting result provided further confirmation as
only 36 kDa band signal amplification were observed. This validated, 36 kDa
band was of rLDHA as specific antibodies were used. To further prove, 36 kDa
band was indeed rLDHA, uninduced, induced and flow through fraction were
investigated. As IPGT was used to overexpressed rLDH by inactivating lac repressor
to allow binding of T7 polymerase to T7 promotor, difference in band intensity
between two fractions should be observed. Based on results, only 36 kDa band
transitioned from dull 36 kDa band in uninduced fraction to bright 36
kDa band in induced fraction. Specific activity and western blotting result were
consistent whereby uninduced fraction contained a much lower specific activity
than induced fraction by 12.47 (μmol/min/mg) and uninduced fraction had a dull signal
amplification compared to moderate signal amplification of induced fraction
respectively. Thus, validated 36 kDa was of rLDHA, overexpression was
successful and pLysS
plasmid in BL21(DE3) E.
coli bacterial cells was working. As junk proteins were discarded into
flowthrough fraction from initial induced fraction via centrifugation of Ni-NTA column, dull 36 kDa band should be
observed. This was due to rLDH being bounded to Ni-NTA
column based on 6x histidine tag affinity for Ni2+. Based on results, only
36 kDa band transitioned from bight 36 kDa band in induced fraction to dull 36
kDa in flowthrough fraction. Specific activity and western blotting result were
consistent whereby flow through fraction contained a much lower specific
activity than induced fraction by 12.47 (μmol/min/mg) and uninduced fraction had a dull
signal amplification compared to moderate signal amplification of induced
fraction respectively. This provided further validated 36 kDa band was
rLDH. However, rLDHA degradation was observed in Fig. 3, with severity increased from
induced to purified fraction due to longer reaction time. Degradation was
likely due to adding insufficient PMSF. This can be rectified by adding
stronger protease inhibitor or higher concentration of PMSF to fraction. But
degradation was not critical as RLDH was still functional based on enzyme
activity of NADH formation. Uninduced and flowthrough fraction were not
affected due to adding PMSF separately thus, sufficient concentration could be
added and majority of rLDHA was eluted to purified sample respectively.
Overall, confirmation of that 36 kDa
band seen in SDS-PAGE by Western blot results proved it expression of rLDHA was
successful with no observed truncation and confirmed enzyme activity of lactate
to pyruvate was indeed rLDH (Triple confirmation test).
3.3
Binding Efficiency and specificity of Ni-NTA column
of
Lactate Dehydrogenase (LDH)
To
accessed binding efficiency of Ni-NTA column, induced and flowthrough fraction
were investigated. Prior to purification, induced fraction contained specific activity
of 12.5 μmol/min/mg and after centrifugation, it dropped to 0.33
μmol/min/mg
in flowthrough fraction. This indicated flowthrough sample contained minimal
levels of rLDH with 38 times less rLDH compared to induced fraction. This was
consistent with SDS-PAGE results, wherby a dull 36 kDa rLDHA band (purple
arrow) in flowthrough fraction compared to bright 36 kDa rLDHA band of induced
sample (orange arrow) was observed. Bands intensity of SDS-PAGE were similar in
western blotting results whereby flowthrough fraction had low amplification
signal of 36 kDa rLDHA band compared to moderate amplification signal in
induced fraction. This indicated: (1)
majority of rLDH remained bounded to Ni-NTA column with 98% binding
efficiency (based on yield), (2) His-tag of rLDH was in right orientation (3)
majority of rLDHA were eluted to purified fraction and was consistent
with purified fraction having highest specific activity. Though, Ni-NTA column binding
to was concluded to be efficient, having 2.05 percentage yield (Table 3)
indicated minor loss of rLDHA to flowthroug fraction. Loss of rLDH was most
likely column reaching maximum binding capacity due to: (1) competition
of binding by junk proteins which conferred similar/higher affinity to rLDH.
(2) Too high concentration of rLDH which overloaded column. However, extend
of loss was insignificant as purified fraction still contained high amounts of
rLDH. This was backed up by purified fraction
containing highest specific activity, thickest and highest amplification
of 36 kDa rLDHA band in SDS-PAGE and western blotting respectively (4 μg of protein was
loaded for all fraction). To accessed specificity of Ni-NTA column,
purified fraction was investigated. Based on results, non-target protein bands
was observed (red arrow) in Fig .1. This could be due to: (1) junk proteins having
similar/higher number of histidine molecules in an adjacent fashion conferring
approximately same affinity as rLDHA, (2) insufficient concentration of
imidazole used to washed column. The former explanation was more likely and was
consistent with hypothesised reason of loss of rLDH to flowthrough fraction.
Thus, indicating Ni-NTA column was not specific to rLDHA due to its
limitation to bind any protein molecules with similar number of histidine
molecules as rLDH. This can be rectified by using a column containing a
specific ligand or antibody to rLDHA
Using a higher concentration of imidazole was not ideal as junk protein
band 1 seemed to bind strongly to Ni2+ based on similar band
intensity with 36 kDa rLDHA. Non-target bands observed in purified fraction were junk
proteins produced by bacteria host as similar bands were observed in uninduced,
induced and flowthrough fraction. This was further confirmed by western
blotting whereby, no signal amplification of non-target bands at 22, 25 and 79
kDa were observed.
3.4 rLDHA purity and yield of Lactate
Dehydrogenase (LDH)
To accessed purity of rLHDA after purification, induced and purified
fraction were investigated. Results indicated after Ni-NTA chromatography, number of bands
in induced fraction drastically reduced to four observable bands in purified
fraction. As discussed in 3.3, 36 kDa band was of rLDHA while remaining bands
were junk proteins. This was consistent with specific activity result whereby
purified fraction specific activity increased by 107.8 μmol/min/mg after
purification of initial induced fraction. This indicated purified fraction
contained 9.6 times more rLDHA than induced fraction thus, purified fraction
became higher in rLDHA purity. In addition, purified fraction had thickest 36
kDa band and highest specific activity indicating it contained the highest
purity of rLDH compared to other fractions. Removed junk protein bands from
induced fraction was observed in followthrough fraction and consistent with
flowthrough fraction containing lower specific activity than purified
fraction. However, overall purified
fraction was not pure due to : (1) Junk protein bands observed in purifed
fraction, (2 partial degradation of
rLDHA observed in western blotting. Junk proteins can be removed by size
exclusion chromatography due to difference in size seen in Table 5 compared to
rLDH. Additional Enzyme assay and SDS-PAGE would then be implemented to
determine if specific activity increased
and a single 36 kDa band obtained respectively. Rectification to rLDHA
degradation was described above in 3.2. To access yield, percentage yield was
looked into. Result indicated purified fraction had yield of 20.8 % which was
relatively low for affinity chromatography. This posed a challenged as
subsequent yield would be lowered if another purification method was
implemented. But purity was deemed of higher priority for downstream
experiments. There was an unexpected tabulation of yield as purified and
flowthrough fraction yield did not add up to ~ 100%. The major loss of yield in
purified fraction was most likely contributed by rLDH degradation seen in western
blotting. Other minor factors that may contributed includes (1) strong
ligand-ligate binding of rLDH to Ni2+ thus, was not eluted, (2) loss
of rLDH during washing step, (3) not storing rLDH in ice thus, loss of
functional enzyme activity. To improve yield, we can use a stronger protease
inhibitor to prevent degradation, use a molecule stronger than imidazole to
compete for binding site and storing rLDH in enzyme in ice box immediately.
3.5
Other anomalous data of Lactate Dehydrogenase (LDH)
Unexpected
induced fraction smearing was noted in Fig.1 whereby it does not have equal
smearing intensity with induced and flow through fraction though equal
proportions of proteins were loaded. This was likely due to: (1) difficulty
experienced during loading of sample into well due to formations of cross-link
webs. Thus, not all sample was loaded. (2) spillage due to improper loading.
This can be rectified by preforming multiple cleaning of well prior to sample
loading. Another unexpected result was induced fraction in Table 2
contained lower protein concentration than uninduced fraction though
theoretically it should be containing more. Induced fraction being more diluted
were ruled out as volume of bacterial culture to lysis buffer was added in
proportion. Likely hypothesis includes: (1) Small sample size of cells
(uninduced) of the same volume has better lysis efficiency releasing more
proteins. (2) Insufficient PMSF added leading to degradation of proteins.
4.0 Conclusion, improvements & Future work of Lactate Dehydrogenase (LDH)
Based on experimental results, silent mutation in rLHDA of previous
experiment did not affect expression and functionality. LDHA has a high activated
status and much level of profile in many of the novel cancers which include a large
mechanism which show every step of gene expression regulation. LDHA enhance
proliferation of cancer cells and still manage the survival of cell. It helps
in invasion and metastasis of cancer cells. It assists cancer cell in immune
escape. This was confirmed with ability to convert lactate into
pyruvate, detected by specific enzyme assay via NADH absorbance at 340 nm. rLDH
presence was further confirmed with SDS-PAGE and Western blot with 36 kDa band
having signal amplification. Ni-NTA column had a high binding efficiency of 98%
but not specific. Loss of 0.02% and unspecific binding was concluded to be
maximum column binding capacity due to binding of non-target proteins with
similar number of histidine molecules to rLDH. Purity of purified fraction did
not achieved single 36 kDa band but can be rectified with size exclusion
chromatography. Yield was deemed to be acceptable and major loss of yield was
concluded to be rLDH partial degradation. There were no major anomalies
throughout the experiments and other anomalies described can be rectified.
Further improvements to current framework induces: (1) further characterization
of rLDHA via total protein estimation (e.g. calorimetry), (2) use a
purification technique that confers higher purification factor, (3) perform
two-step purification methods to determine if constant specific activity
is achieved, (4) perform additional
layer of purity check such as mass spectrophotometry or N-terminal sequencing.
With validation that rLDHA silent mutation in pET11-H6α did not
affect overall protein expression and function, further downstream experiments
can be implemented. The next phase would be to study its structure to develop
potential novel therapeutic agents in cancer, e.g. antagonistic inhibitors.
Reference of Lactate Dehydrogenase (LDH)
Betts, J. C., Lukey, P. T., Robb, L. C.,
McAdam, R. A., & Duncan, K. (2002, February 28). Evaluation of a nutrient
starvation model of Mycobacterium tuberculosis persistence by gene and protein
expression profiling. Retrieved from
https://onlinelibrary.wiley.com/doi/full/10.1046/j.1365-2958.2002.02779.x
Kang, Y., Son, M. S., & Hoang, T. T. (2007,
October). One step engineering of T7-expression strains for protein production:
increasing the host-range of the T7-expression system. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2040312/
Kim, J.-whan, & Dang, C. V. (2006,
September 15). Cancer's Molecular Sweet Tooth and the Warburg Effect. Retrieved
from https://cancerres.aacrjournals.org/content/66/18/8927
M. H. Zwietering, I. Jongenburger, F. M. Rombouts
& K. van 't Riet (1990, June). Modelling of
the bacterial growth curve. Retrieved from https://aem.asm.org/content/56/6/1875/article-info
Overview
of Electrophoresis: Thermo Fisher Scientific - US. (n.d.). Retrieved from https://www.thermofisher.com/sg/en/home/life-science/protein-biology/protein-biology-learning-center/protein-biology-resource-library/pierce-protein-methods/overview-electrophoresis.html
Tabor, S.
(2001, May 1). Expression Using the T7 RNA Polymerase/Promoter System.
Retrieved from https://currentprotocols.onlinelibrary.wiley.com/doi/abs/10.1002/0471142727.mb1602s11
Zhao, D., Zou, S.-W., Liu, Y., Zhou, X., Mo,
Y., Wang, P., … Guan, K.-L. (2013, April 15). Lysine-5 acetylation negatively
regulates lactate dehydrogenase A and is decreased in pancreatic cancer.
Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3885615/
Zhai, Xiaoming, Yang, Yang, Zhu, Wu, &
Yiwei. (2013, December 1). Inhibition of LDH-A by oxamate induces G2/M arrest,
apoptosis and increases radiosensitivity in nasopharyngeal carcinoma cells.
Retrieved from https://www.spandidos-publications.com/10.3892/or.2013.2735